Patient Risk Subgroups Predict Benefit of Adjuvant Chemotherapy in Stage II Rectal Cancer Patients Following Neoadjuvant Chemoradiation and Total Mesorectal Excision
Titel:
Patient Risk Subgroups Predict Benefit of Adjuvant Chemotherapy in Stage II Rectal Cancer Patients Following Neoadjuvant Chemoradiation and Total Mesorectal Excision
Auteur:
Naffouje, Samer Sabesan, Arvind Powers, Benjamin D. Dessureault, Sophie Sanchez, Julian Schell, Michael Imanirad, Iman Sahin, Ibrahim Xie, Hao Felder, Seth